L-50 4312 Pill - gray oval, 9mm
Generic Name: lasmiditan
Pill with imprint L-50 4312 is Gray, Oval and has been identified as Reyvow 50 mg. It is supplied by Eli Lilly and Company.
Reyvow is used in the treatment of Migraine and belongs to the drug class antimigraine agents. Reyvow 50 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for L-50 4312
Reyvow
- Generic Name
- lasmiditan
- Imprint
- L-50 4312
- Strength
- 50 mg
- Color
- Gray
- Size
- 9.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antimigraine agents
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-4312
See also:
Ubrelvy
Ubrelvy (ubrogepant) tablets are used for the acute treatment of migraine. Includes Ubrelvy side ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Qulipta
Qulipta is used to help prevent episodic or chronic migraine headaches in adults. Qulipta is an ...
Celebrex
Celebrex is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation. Learn about ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Advil
Advil (ibuprofen) reduces fever, pain and inflammation caused by headaches, toothaches, arthritis ...
Voltaren
Voltaren (diclofenac) is used to treat pain or inflammation caused by arthritis or ankylosing ...
Reglan
Reglan (metoclopramide) is used to treat heartburn caused by gastric reflux. Includes Reglan side ...
More about Reyvow (lasmiditan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (23)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antimigraine agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.